Effect of androgen on ornithine decarboxylase activity in androgen-dependent mouse mammary tumor (Shionogi Carcinoma 115) and its androgen-independent subline (CS 2).
The activity of ornithine decarboxylase in androgen-dependent mouse mammary tumor (Shionogi Carcinoma 115) was reduced to 25% by castration of tumor-bearing mice and restored to the normal level 12 h after administration of testosterone or 5 alpha-dihydrotestosterone. Administration of estradiol-17 beta to the tumor-bearing castrated mice also stimulated the enzyme activity while progesterone and cortisol had little effect. On the other hand, the enzyme activity was affected by neither castration nor androgen injection to CS 2, which is a subline of SC 115 and completely independent of androgen for growth. The inhibition of ornithine decarboxylase activity in SC 115 by injecting alpha-difluoromethylornithine did not affect the enhancement of RNA polymerase I activity by androgen, showing independent elevation of the levels of the two enzymes by androgen.
D000728:Androgens / Q000008:administration & dosage / Q000378:metabolism*; D000818:Animals; D002277:Carcinoma / Q000201:enzymology*; D002460:Cell Line; D004958:Estradiol / Q000378:metabolism; D007279:Injections, Subcutaneous; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000201:enzymology*; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D009919:Orchiectomy; D009955:Ornithine Decarboxylase / Q000378:metabolism*; D011374:Progesterone / Q000378:metabolism; D012318:RNA Polymerase I / Q000378:metabolism; D013739:Testosterone / Q000378:metabolism
D000728:Androgens; D013739:Testosterone; D011374:Progesterone; D004958:Estradiol; D012318:RNA Polymerase I; D009955:Ornithine Decarboxylase